Jim Miller

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report, a monthly newsletter covering the contract drug development industry. A trial subscription can be obtained by calling 703.383.4903, by faxing 703.383.4905, by e-mailing info@pharmsource.com, or on the Web at www.pharmsource.com.

A new analysis highlights growth drivers and challenges for clinical supply-chain services.

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.

Apopular definition of insanity is repeating the same task over and over again while expecting a different result. It would appear, therefore, that many people in the contract services industry think the major global bio/pharma companies are insane.

Contract-service providers are expanding their offerings in this slow-growth environment.

A new analysis highlights growth drivers and challenges for clinical supply-chain services.

Contract-service providers are expanding their offerings in this slow-growth environment.

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.

In the current slow growth environment, service providers are looking to tactical expansions, as well as more ambitious strategic service expansions.

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.